RxDoctor Payments Data

Nicholas Placentra, DO

Family Medicine · Boone, NCNPI 1760493894

Payments from drug & device makers

$733in general payments, 2019–2025

Across 40 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$99
  • AbbVie$95
  • Astellas Pharma US Inc$92
  • Novo Nordisk$77
  • Lilly USA, LLC$63
  • Exact Sciences$36
  • plus $271 from 13 others

What the payments were for

  • Food & beverage$72098%
  • Entertainment$132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$733 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,578
Medicare patients
66
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide104$122,651
EliquisApixaban79$101,054
OzempicSemaglutide57$81,723
JardianceEmpagliflozin52$67,217
TrulicityDulaglutide30$52,359
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$42,171
RybelsusSemaglutide17$38,099
XareltoRivaroxaban13$19,913
Repatha SureclickEvolocumab14$19,355
Repatha SyringeEvolocumab13$18,302
FarxigaDapagliflozin Propanediol17$15,164
InvokanaCanagliflozin12$11,582
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$10,447
Breo ElliptaFluticasone/Vilanterol16$7,765
LantusInsulin Glargine,hum.Rec.Anlog15$6,568

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$63$176,764147 claims
Novo NordiskOzempic, Rybelsus$77$119,82274 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$99$60,38393 claims
AstraZenecaFarxiga$33$15,16417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Boone

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →